Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: An atypical case;Dermatomyosite et pneumopathie interstitielle rapidement évolutive associées aux auto-anticorps anti-MDA-5: une présentation clinique atypique

Annales de Dermatologie et de Venereologie

Volumn 140, Issue 10, 2013, Pages 628-634

  Girard, C ^a   Vincent, T ^a   Bessis, D ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Acquired ichthyosis; Dermatomyositis; Interstitial lung disease; MDA 5 antibodies

Indexed keywords

ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MDA 5 ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE COURSE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MALE; SKIN EXAMINATION; TREATMENT RESPONSE;

ACQUIRED ICHTHYOSIS; ANTICORPS MDA-5; DERMATOMYOSITE; DERMATOMYOSITIS; ICHTYOSE ACQUISE; INTERSTITIAL LUNG DISEASE; MDA-5 ANTIBODIES; PNEUMOPATHIE INTERSTITIELLE;

ACUTE DISEASE; ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; BETA-THALASSEMIA; CALCINOSIS; DEAD-BOX RNA HELICASES; DERMATOMYOSITIS; ERYTHEMA; HUMANS; ICHTHYOSIS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; SKIN ULCER; SMOKING;

EID: 84885070505     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2013.04.083     Document Type: Article

References (24)

1. Y. Troyanov, I.N. Targoff, J.L. Tremblay, J.R. Goulet, Y. Raymond, and J.L. Senécal Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients Medicine (Baltimore) 84 2005 231 249
2. S. Sato, M. Hirakata, M. Kuwana, A. Suwa, S. Inada, T. Mimori, and T. Nishikawa Autoantibodies to a 140-kd polypeptide CADM-140, in Japanese patients with clinically amyopathic dermatomyositis Arthritis Rheum 52 2005 1571 1576
3. T. Gono, Y. Kawaguchi, T. Satoh, M. Kuwana, Y. Katsumata, and K. Takagi Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis Rheumatology (Oxford) 49 2010 1713 1719
4. Y. Hamaguchi, M. Kuwana, K. Hoshino, M. Hasegawa, K. Kaji, and T. Matsushita Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study Arch Dermatol 147 2011 391 398
5. J. Sibilia, E. Chatelus, A. Meyer, J.E. Gottenberg, C. Sordet, and J. Goetz Comment faire le diagnostic et mieux comprendre les myopathies inflammatoires ? L'utilité des auto-anticorps Presse Med 39 2010 1010 1025
6. S. Sato, K. Hoshino, T. Satoh, T. Fujita, Y. Kawakami, and T. Fujita RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease Arthritis Rheum 60 2009 2193 2200
7. K. Hoshino, Y. Muro, K. Sugiura, Y. Tomita, R. Nakashima, and T. Mimori Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis Rheumatology (Oxford) 49 2010 1726 1733
8. N.F. Chaisson, J. Paik, A.M. Orbai, L. Casciola-Rosen, D. Fiorentino, and S. Danoff A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature Medicine (Baltimore) 91 2012 220 228
9. K. Fujikawa, A. Kawakami, K. Kaji, M. Fujimoto, S. Kawashiri, and N. Iwamoto Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study Scand J Rheumatol 38 2009 263 267
10. Z.A. Zahr, and A.N. Baer Malignancy in myositis Curr Rheumatol Rep 13 2011 208 215
11. D. Fiorentino, L. Chung, J. Zwerner, A. Rosen, and L. Casciola-Rosen The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study J Am Acad Dermatol 65 2011 25 34
12. H. Cao, M. Pan, Y. Kang, Q. Xia, X. Li, and X. Zhao Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody Arthritis Care Res (Hoboken) 64 2012 1602 1610
13. M. Inuzuka, K. Tomita, Y. Tokura, and M. Takigawa Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma Br J Dermatol 144 2001 416 417
14. S. Urrutia, F. Vazquez, L. Requena, and E. Sanchez Yus Acquired ichthyosis associated with dermatomyositis J Am Acad Dermatol 16 1987 627 629
15. S. Slimani, A. Abdessemed, A. Haddouche, and A. Ladjouze-Rezig Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate Joint Bone Spine 77 2010 70 72
16. R.E. Fisler, M.G. Liang, R.C. Fuhlbrigge, A. Yalcindag, and R.P. Sundel Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis J Am Acad Dermatol 47 2002 505 511
17. A.M. Sallum, F.C. Pivato, U. Doria-Filho, N.E. Aikawa, B.L. Liphaus, and S.K. Marie Risk factors associated with calcinosis of juvenile dermatomyositis J Pediatr (Rio J) 84 2008 68 74
18. M. Kavala, S. Sudogan, B. Can, I. Zindanci, I. Kuru, and S. Beyhan An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis Clin Exp Dermatol 34 2009 115 116
19. H. Gunawardena, L.R. Wedderburn, H. Chinoy, Z.E. Betteridge, J. North, and W.E. Ollier Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis Arthritis Rheum 60 2009 1807 1814
20. K. Sugiura, Y. Muro, and M. Akiyama Autoantibodies to nuclear matrix protein 2/MJ in adult-onset dermatomyositis with severe calcinosis J Am Acad Dermatol 67 2012 e167-8
21. K. Tanizawa, T. Handa, R. Nakashima, T. Kubo, Y. Hosono, and K. Watanabe HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody Respir Med 105 2011 1380 1387
22. S. Sato, M. Kuwana, T. Fujita, and Y. Suzuki Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease Mod Rheumatol 23 2013 496 502
23. Y. Muro, K. Sugiura, K. Hoshino, and M. Akiyama Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission Rheumatology (Oxford) 51 2012 800 804
24. T. Gono, S. Sato, Y. Kawaguchi, M. Kuwana, M. Hanaoka, and Y. Katsumata Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody- positivedermatomyositis Rheumatology (Oxford) 51 2012 1563 1570